BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30085056)

  • 1. Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis.
    O'Shaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Eur Heart J; 2019 Mar; 40(11):887-898. PubMed ID: 30085056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient characteristics and outcomes by GN subtype in ESRD.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Clin J Am Soc Nephrol; 2015 Jul; 10(7):1170-8. PubMed ID: 26092830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Transplantation Rates Across Glomerulonephritis Subtypes in the United States.
    OʼShaughnessy MM; Liu S; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Transplantation; 2017 Oct; 101(10):2636-2647. PubMed ID: 28207635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in initial treatment modality for end-stage renal disease among glomerulonephritis subtypes in the USA.
    O'Shaughnessy MM; Montez-Rath ME; Lafayette RA; Winkelmayer WC
    Nephrol Dial Transplant; 2016 Feb; 31(2):290-8. PubMed ID: 26610594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep disordered breathing and cardiovascular risk in older patients initiating dialysis in the United States: a retrospective observational study using medicare data.
    Tuohy CV; Montez-Rath ME; Turakhia M; Chang TI; Winkelman JW; Winkelmayer WC
    BMC Nephrol; 2016 Feb; 17():16. PubMed ID: 26861778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Cardiovascular Disease and Mortality in Young Adults With End-stage Renal Disease: An Analysis of the US Renal Data System.
    Modi ZJ; Lu Y; Ji N; Kapke A; Selewski DT; Dietrich X; Abbott K; Nallamothu BK; Schaubel DE; Saran R; Gipson DS
    JAMA Cardiol; 2019 Apr; 4(4):353-362. PubMed ID: 30892557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis.
    Gómez-Puerta JA; Feldman CH; Alarcón GS; Guan H; Winkelmayer WC; Costenbader KH
    Arthritis Care Res (Hoboken); 2015 Oct; 67(10):1453-62. PubMed ID: 25624071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study.
    Winkelmayer WC; Chang TI; Mitani AA; Wilhelm-Leen ER; Ding V; Chertow GM; Brookhart MA; Goldstein BA
    Am J Kidney Dis; 2015 Jul; 66(1):106-13. PubMed ID: 25943715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis.
    Ward MM
    Am J Kidney Dis; 2000 Sep; 36(3):516-25. PubMed ID: 10977783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kidney Transplantation and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis: A Nationwide Cohort Study.
    Jorge A; Fu X; Cook C; Lu N; Zhang Y; Choi HK; Wallace ZS
    Arthritis Care Res (Hoboken); 2022 Nov; 74(11):1829-1834. PubMed ID: 34121367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the contribution of the cause of kidney disease to prognosis in CKD: results from the Study of Heart and Renal Protection (SHARP).
    Haynes R; Staplin N; Emberson J; Herrington WG; Tomson C; Agodoa L; Tesar V; Levin A; Lewis D; Reith C; Baigent C; Landray MJ;
    Am J Kidney Dis; 2014 Jul; 64(1):40-8. PubMed ID: 24613056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.
    Reule S; Sexton DJ; Solid CA; Chen SC; Collins AJ; Foley RN
    Am J Kidney Dis; 2014 Oct; 64(4):592-9. PubMed ID: 25134777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data.
    Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E
    Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
    Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
    Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplantation Outcomes across GN Subtypes in the United States.
    O'Shaughnessy MM; Liu S; Montez-Rath ME; Lenihan CR; Lafayette RA; Winkelmayer WC
    J Am Soc Nephrol; 2017 Feb; 28(2):632-644. PubMed ID: 27432742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative incidence of ESRD versus cardiovascular mortality in proteinuric type 2 diabetes and nephropathy: results from the DIAMETRIC (Diabetes Mellitus Treatment for Renal Insufficiency Consortium) database.
    Packham DK; Alves TP; Dwyer JP; Atkins R; de Zeeuw D; Cooper M; Shahinfar S; Lewis JB; Lambers Heerspink HJ
    Am J Kidney Dis; 2012 Jan; 59(1):75-83. PubMed ID: 22051245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between attributed cause of end-stage renal disease and risk of death in Brazilian patients receiving renal replacement therapy.
    Batista PB; Lopes AA; Costa FA
    Ren Fail; 2005; 27(6):651-6. PubMed ID: 16350813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-recovery from dialysis-requiring acute kidney injury and short-term mortality and cardiovascular risk: a cohort study.
    Lee BJ; Hsu CY; Parikh RV; Leong TK; Tan TC; Walia S; Liu KD; Hsu RK; Go AS
    BMC Nephrol; 2018 Jun; 19(1):134. PubMed ID: 29890946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations Between Kidney Histopathologic Lesions and Incident Cardiovascular Disease in Adults With Chronic Kidney Disease.
    Buckley LF; Schmidt IM; Verma A; Palsson R; Adam D; Shah AM; Srivastava A; Waikar SS
    JAMA Cardiol; 2023 Apr; 8(4):357-365. PubMed ID: 36884237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.